Iran to Start Phase III of Clinical Trial of Cuban-Iranian COVID-19 Vaccine

Iran is to launch phase three of the clinical trial of the coronavirus vaccine jointly produced by Iran and Cuba.

“Phase three of the clinical trial of this vaccine kicks off on Monday, April 26, 2021, in seven provinces and eight medical sciences universities across the nation, and some 24,000 people will receive jabs in this phase,” said the head of the Pasteur Institute of Iran, which is jointly producing the vaccine with Cuba.

“The 44,000 people who were injected with the Iranian-Cuban vaccine received the first dose, and based on a study conducted during phases one and two, this vaccine can create more than 85% immunity,” he added.

He also said COVID-19 vaccination should be free of charge for all as decided by the health ministry.

IFP Editorial Staff

The IFP Editorial Staff is composed of dozens of skilled journalists, news-writers, and analysts whose works are edited and published by experienced editors specialized in Iran News. The editor of each IFP Service is responsible for the report published by the Iran Front Page (IFP) news website, and can be contacted through the ways mentioned in the "IFP Editorial Staff" section.